Published in Oral Surg Oral Med Oral Pathol Oral Radiol Endod on October 01, 2002
Localized tongue Amyloidosis in a Patient with Neurofibromatosis type II. Head Neck Pathol (2011) 0.80
Extramedullary myeloma in an HIV-seropositive subject. Literature review and report of an unusual case. Head Face Med (2009) 0.79
Macroglossia due to Systemic Amyloidosis: Is There a Role for Radiotherapy? Case Rep Oncol (2011) 0.75
Involvement of oral tissues by AL amyloidosis: a literature review and report of eight new cases. Clin Oral Investig (2015) 0.75
Prognostic index for adult patients with acute myeloid leukemia in first relapse. J Clin Oncol (2005) 3.15
Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 2.40
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma. J Clin Oncol (2008) 2.32
High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study. J Clin Oncol (2013) 2.22
The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands. Leuk Res (2012) 2.18
Oral lichen planus and the p53 family: what do we know? J Oral Pathol Med (2010) 2.04
Pigmented lesions of the oral mucosa and perioral tissues: a flow-chart for the diagnosis and some recommendations for the management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 1.88
Oral malignant melanoma: a review of the literature. Oral Oncol (2006) 1.70
Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. Br J Haematol (2010) 1.66
18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review. Haematologica (2006) 1.61
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial. Blood (2007) 1.60
Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography. Eur J Nucl Med Mol Imaging (2006) 1.58
Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON-SAKK co-operative group studies. Br J Haematol (2005) 1.54
Long-term follow-up of tandem autologous stem-cell transplantation in multiple myeloma. J Clin Oncol (2010) 1.48
Palifermin and palmar-plantar erythrodysesthesia. Br J Haematol (2007) 1.45
Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood (2006) 1.31
Management of Frey syndrome. Head Neck (2007) 1.24
The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2003) 1.23
Birt-Hogg-Dubé syndrome: clinical and genetic studies of 20 families. J Invest Dermatol (2007) 1.21
Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET. Eur J Nucl Med Mol Imaging (2012) 1.21
Penile lesions and human papillomavirus in male sexual partners of women with cervical intraepithelial neoplasia. J Am Acad Dermatol (2002) 1.14
Pearly penile papules: still no reason for uneasiness. J Am Acad Dermatol (2003) 1.13
Cheilitis granulomatosa: overview of 13 patients with long-term follow-up--results of management. Int J Dermatol (2002) 1.13
Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 1.12
Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic. Br J Haematol (2002) 1.11
Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol (2002) 1.11
Head and neck mucosal melanoma: experience with 42 patients, with emphasis on the role of postoperative radiotherapy. Head Neck (2008) 1.11
HPV-associated flat penile lesions in men of a non-STD hospital population: less frequent and smaller in size than in male sexual partners of women with CIN. Int J Cancer (2005) 1.09
Management of adult soft tissue sarcomas of the head and neck. Oral Oncol (2010) 1.08
Prognostic factors in adult soft tissue sarcomas of the head and neck: a single-centre experience. Oral Oncol (2006) 1.06
A noninvasive genetic screening test to detect oral preneoplastic lesions. Lab Invest (2005) 1.06
Adenoid cystic carcinoma of the head and neck: a single-center analysis of 105 consecutive cases over a 30-year period. Oral Oncol (2013) 1.05
Oral proliferative verrucous leukoplakia revisited. Oral Oncol (2007) 1.04
Ameloblastoma of the jaws: a critical reappraisal based on a 40-years single institution experience. Oral Oncol (2009) 1.04
Congenital epulis of the jaw: a series of five cases and review of literature. Pediatr Surg Int (2008) 1.04
The relevance of uniform reporting in oral leukoplakia: definition, certainty factor and staging based on experience with 275 patients. Med Oral Patol Oral Cir Bucal (2013) 1.02
Proteoglycans guide SDF-1-induced migration of hematopoietic progenitor cells. J Leukoc Biol (2002) 1.01
Autologous peripheral blood stem cell transplantation for acute myeloid leukemia. Blood (2011) 1.01
Melanocytic nevi of the oral mucosa - no evidence of increased risk for oral malignant melanoma: an analysis of 119 cases. Oral Oncol (2007) 1.00
Ectomesenchymal chondromyxoid tumor of the anterior tongue. Report of two cases. Oral Oncol (2003) 0.99
Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int J Cancer (2003) 0.99
Oral malignant melanoma: the amsterdam experience. J Oral Maxillofac Surg (2007) 0.99
Recurrence rate of keratocystic odontogenic tumor after conservative surgical treatment without adjunctive therapies - A 35-year single institution experience. Oral Oncol (2010) 0.98
Darier disease: a case report. Br J Oral Maxillofac Surg (2005) 0.98
Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy. Br J Clin Pharmacol (2012) 0.96
DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma. Clin Cancer Res (2007) 0.95
Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia. Oral Oncol (2009) 0.94
Lupus miliaris disseminatus faciei: a distinctive rosacea-like syndrome and not a granulomatous form of rosacea. Dermatology (2003) 0.91
Screening for oral precancer with noninvasive genetic cytology. Cancer Prev Res (Phila) (2009) 0.90
A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma. Cancer Res (2002) 0.89
Aprotinin does not diminish blood loss in elective operations for infrarenal abdominal aneurysms: a randomized double-blind controlled trial. Ann Vasc Surg (2006) 0.89
Severe granulomatous inflammatory response induced by injection of polyacrylamide gel into the facial tissue. Arch Facial Plast Surg (2004) 0.88
Oral malignant melanoma associated with pseudoepitheliomatous hyperplasia. Report of a case. J Cutan Pathol (2006) 0.88
Observer variation in the histopathologic assessment of extranodal tumor spread in lymph node metastases in the neck. Head Neck (2011) 0.87
Genetic and clinical mosaicism in a patient with neurofibromatosis type 1. Hum Genet (2003) 0.87
Physical exercise interventions in haematological cancer patients, feasible to conduct but effectiveness to be established: a systematic literature review. Cancer Treat Rev (2008) 0.86
Dental management of patients using antithrombotic drugs: critical appraisal of existing guidelines. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 0.86
Copy number gain at 8q12.1-q22.1 is associated with a malignant tumor phenotype in salivary gland myoepitheliomas. Genes Chromosomes Cancer (2009) 0.86
Management recommendations for invasive dental treatment in patients using oral antithrombotic medication, including novel oral anticoagulants. Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 0.85
Proliferative verrucous leukoplakia; a critical appraisal of the diagnostic criteria. Med Oral Patol Oral Cir Bucal (2013) 0.85
Molecular screening of oral precancer. Oral Oncol (2013) 0.84
A de novo FLCN mutation in a patient with spontaneous pneumothorax and renal cancer; a clinical and molecular evaluation. Fam Cancer (2013) 0.84
Early apoptosis largely accounts for functional impairment of CD34+ cells in frozen-thawed stem cell grafts. J Hematother Stem Cell Res (2002) 0.84
Salivary gland carcinosarcoma: oligonucleotide array CGH reveals similar genomic profiles in epithelial and mesenchymal components. Oral Oncol (2008) 0.83
Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with ⁹⁰Yttrium ibritumomab tiuxetan-BEAM and autologous stem cell transplantation. Br J Haematol (2012) 0.83
Practical feasibility of outcomes research in oncology: lessons learned in assessing drug use and cost-effectiveness in The Netherlands. Eur J Cancer (2012) 0.82
Comparative evaluation of genetic assays to identify oral pre-cancerous fields. J Oral Pathol Med (2008) 0.82
Cost-effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population-based study. Eur J Haematol (2014) 0.82
In vitro model for hematopoietic progenitor cell homing reveals endothelial heparan sulfate proteoglycans as direct adhesive ligands. J Leukoc Biol (2003) 0.81
Bone marrow stromal proteoglycans regulate megakaryocytic differentiation of human progenitor cells. Exp Cell Res (2004) 0.81
Reinfusion of unprocessed, granulocyte colony-stimulating factor-stimulated whole blood allows dose escalation of 186Relabeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I dose escalation study. Clin Cancer Res (2002) 0.81
Prognostic value of DNA ploidy status in patients with oral leukoplakia. Oral Oncol (2011) 0.81
[Spontaneous pneumothorax as the first manifestation of a hereditary condition with an increased renal cancer risk]. Ned Tijdschr Geneeskd (2009) 0.80
Cheilitis granulomatosa and optic neuropathy as rare extraintestinal manifestations of Crohn's disease. J Clin Gastroenterol (2002) 0.79
Economic assessment on the management of chronic lymphocytic leukaemia. Expert Opin Pharmacother (2005) 0.79
Distress and quality of life after autologous stem cell transplantation: a randomized clinical trial to evaluate the outcome of a web-based stepped care intervention. BMC Cancer (2010) 0.79
Patients with oral cancer developing from pre-existing oral leukoplakia: do they do better than those with de novo oral cancer? J Oral Pathol Med (2008) 0.79
The pathogenesis of pneumothorax in Birt-Hogg-Dubé syndrome: a hypothesis. Respirology (2014) 0.79
Granular cell tumor of the oral cavity; a case series including a case of metachronous occurrence in the tongue and the lung. Med Oral Patol Oral Cir Bucal (2015) 0.78
Clinicopathological evaluation of 164 dental follicles and dentigerous cysts with emphasis on the presence of odontogenic epithelium in the connective tissue. The hypothesis of "focal ameloblastoma". Med Oral Patol Oral Cir Bucal (2013) 0.78
Treating dental patients who use oral antithrombotic medication: a survey of dentists in the Netherlands. J Am Dent Assoc (2011) 0.78
Cognitive coping style (monitoring and blunting) and the need for information, information satisfaction and shared decision making among patients with haematological malignancies. Psychooncology (2014) 0.78
Unilateral condylar hyperactivity: a histopathologic analysis of 47 patients. J Oral Maxillofac Surg (2010) 0.78
Proposal for a new staging system for osteoradionecrosis of the mandible. Med Oral Patol Oral Cir Bucal (2014) 0.78
Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21, and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based PHAROS-registry. Ann Hematol (2014) 0.77
18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma. Br J Haematol (2003) 0.77
Costs of multiple myeloma and associated skeletal-related events in The Netherlands. Expert Rev Pharmacoecon Outcomes Res (2004) 0.77
Homing and clonogenic outgrowth of CD34(+) peripheral blood stem cells: a role for L-selectin? Exp Hematol (2002) 0.77
Oral non-squamous malignant tumors; diagnosis and treatment. Med Oral Patol Oral Cir Bucal (2007) 0.77
Reduced supportive capacity of bone marrow stroma upon chemotherapy is mediated via changes in glycosaminoglycan profile. Matrix Biol (2007) 0.76
Classic pseudoxanthoma elasticum in a patient with sickle cell disease. J Am Acad Dermatol (2007) 0.76
Disease scoring systems for oral lichen planus; a critical appraisal. Med Oral Patol Oral Cir Bucal (2015) 0.76
Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 x 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphoma. Br J Haematol (2002) 0.76